Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)
Public ClinicalTrials.gov record NCT02145182. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multi-center Study of Eculizumab for the Prevention of Delayed Graft Function After Kidney Transplantation in Adult Subjects at Increased Risk of Delayed Graft Function.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to determine if eculizumab is safe and could be used to prevent delayed graft function (DGF) following kidney transplantation.
Study identification
- NCT ID
- NCT02145182
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 288 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 21, 2014 (Actual)
- Primary completion
- Nov 22, 2016 (Actual)
- Completion
- Nov 22, 2016 (Actual)
- Last update posted
- Dec 17, 2018
2014 – 2016
United States locations
- U.S. sites
- 32
- U.S. states
- 23
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Phoenix | Arizona | 85054 | — |
| Not listed | Los Angeles | California | 90024 | — |
| Not listed | Palo Alto | California | 94304 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | San Francisco | California | 94143 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | New Haven | Connecticut | 06520 | — |
| Not listed | Washington D.C. | District of Columbia | 20007 | — |
| Not listed | Tampa | Florida | 33606 | — |
| Not listed | Augusta | Georgia | 30912 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Lexington | Kentucky | 40536 | — |
| Not listed | New Orleans | Louisiana | 70121 | — |
| Not listed | Baltimore | Maryland | 21287 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Minneapolis | Minnesota | 55455 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Livingston | New Jersey | 07039 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | New York | New York | 10065 | — |
| Not listed | The Bronx | New York | 10467 | — |
| Not listed | Chapel Hill | North Carolina | 27599 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Charlottesville | Virginia | 22903 | — |
| Not listed | Richmond | Virginia | 23298 | — |
| Not listed | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02145182, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02145182 live on ClinicalTrials.gov.